Literature DB >> 31120286

Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.

Rebecca M Craft1, Stevie C Britch1, Nate W Buzitis2, Brian H Clowers2.   

Abstract

Given the use of cannabis as an analgesic by a broadening age range of patients, the aim of this study was to determine whether the antinociceptive effects of Δ9-tetrahydrocannabinol (THC) differ by age. The antinociceptive potency and efficacy of THC (1.0-18 mg/kg ip) was compared in male and female rats aged postnatal day 35-40 (adolescent), 60-70 (young adult), and 291-325 (middle-aged adult), using warm water tail withdrawal and paw pressure tests. Motoric effects of THC were assessed using a locomotor activity test. On the tail withdrawal test, THC was significantly more effective in middle-aged adult than in young adult rats and significantly less effective in adolescent than in young adult rats. Similar but smaller age-related differences were observed on the paw pressure test. Sex differences in THC's antinociceptive effects were consistent across the 3 ages examined, with greater THC effects observed in females than males of each age. Age-related differences in THC's locomotor-suppressing effect were also observed, with the greatest effect in young adult female rats. Serum THC levels were slightly higher in adolescent than in young adult rats, and levels of the active metabolites 11-OH-THC and cannabinol, as well as the inactive metabolite 11-nor-9-carboxy-THC, did not differ between adolescent and young adult rats. These results suggest that the pain-relieving effects of THC may be more limited in adolescents than in adults and that these age-related differences in THC effect are not attributable to differential absorption or metabolism of THC. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31120286     DOI: 10.1037/pha0000257

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  7 in total

1.  Pharmacokinetic and pharmacodynamic properties of aerosolized ("vaped") THC in adolescent male and female rats.

Authors:  C M Ruiz; A Torrens; V Lallai; E Castillo; L Manca; M X Martinez; D N Justeson; C D Fowler; D Piomelli; S V Mahler
Journal:  Psychopharmacology (Berl)       Date:  2021-09-08       Impact factor: 4.530

2.  Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.

Authors:  Catherine F Moore; Elise M Weerts
Journal:  Psychopharmacology (Berl)       Date:  2021-10-15       Impact factor: 4.415

3.  Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats.

Authors:  Ilayda Alkislar; Alison R Miller; Andrea G Hohmann; Aymen H Sadaka; Xuezhu Cai; Praveen Kulkarni; Craig F Ferris
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-12-13

Review 4.  Translational models of cannabinoid vapor exposure in laboratory animals.

Authors:  Catherine F Moore; Jeffrey W Stiltner; Catherine M Davis; Elise M Weerts
Journal:  Behav Pharmacol       Date:  2022-04-01       Impact factor: 2.293

5.  Appetitive, antinociceptive, and hypothermic effects of vaped and injected Δ-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex.

Authors:  Catherine F Moore; Catherine M Davis; Eric L Harvey; Michael A Taffe; Elise M Weerts
Journal:  Pharmacol Biochem Behav       Date:  2021-01-23       Impact factor: 3.533

6.  Pharmacokinetic, behavioral, and brain activity effects of Δ9-tetrahydrocannabinol in adolescent male and female rats.

Authors:  Christina M Ruiz; Alexa Torrens; Erik Castillo; Christina R Perrone; Jenny Cevallos; Victoria C Inshishian; Eden V Harder; Drew N Justeson; Marilyn A Huestis; Vivek Swarup; Daniele Piomelli; Stephen V Mahler
Journal:  Neuropsychopharmacology       Date:  2020-09-14       Impact factor: 7.853

7.  Acute Delta 9-tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats.

Authors:  Kyle A Windisch; Sanoara Mazid; Megan A Johnson; Elina Ashirova; Yan Zhou; Lennox Gergoire; Sydney Warwick; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Synapse       Date:  2021-10       Impact factor: 2.537

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.